| Mepha Pharma AG - Venlafaxin-Mepha Teva 37.5 mg, Tabletten |
| 60135 | | 01 | | Venlafaxin-Mepha Teva 37.5 mg | | Tabletten | | N06AX16 | | Venlafaxin | | 15.04.2010 | | |
|
| Composition |
| venlafaxinum 37.5 mg ut venlafaxini hydrochloridum, lactosum monohydricum 97.029 mg, silica colloidalis anhydrica, magnesii stearas, carboxymethylamylum natricum A corresp. natrium max. 0.315 mg, E 172 (flavum), E 172 (rubrum), pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Venlafaxine | 37.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Venlafaxine | 37.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | E 172 | | color. | | Lactose Monohydrate | 97.029 mg | | | Magnesii Stearas | | | | Pro Compresso | | | | Silica Colloidalis Anhydrica | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 Comprimé(s) | 10.00 | 19.65 | B | | Oui | | 003 | 28 | 9.75 | 27.10 | B | LS | Non | | 004 | 98 | 33.42 | 52.75 | B | LS | Non |
|
